Join the Vaginal Yeast Infection group to help and get support from people like you.
Vaginal Yeast Infection News
Related terms: Candidiasis, Vaginal, Monilial vaginitis, Thrush, Vaginal, Vaginal Candidiasis, Vaginal Thrush, Yeast Infection, vaginal, Thrush
Scynexis Announces FDA Approval of Second Indication for Brexafemme (ibrexafungerp tablets) for Reduction in Incidence of Recurrent Vulvovaginal Candidiasis
Brexafemme, an oral, non-azole medication, is the first and only FDA-approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the reduction in the incidence of recurrent VVC....
FDA Approves Vivjoa (oteseconazole) for the Treatment of Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)
DURHAM, N.C.--(BUSINESS WIRE)-- The U.S. Food and Drug Administration (FDA) approved Vivjoa (oteseconazole capsules), an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal...
FDA Approves Brexafemme (ibrexafungerp) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections
JERSEY CITY, N.J., June 02, 2021 (GLOBE NEWSWIRE) – Scynexis, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...
FDA Medwatch Alert: Fluconazole (Diflucan): Drug Safety Communication - FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy
ISSUE: FDA is evaluating the results of a Danish study that concludes there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) for yeast infections. FDA is also...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
Monistat, fluconazole, Monistat 3, Monistat 7, Diflucan, ketoconazole, terconazole